SEC Form 4 · accession 0001209191-18-035292
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darrin Uecker
Officer — CEO and President · Director
Period of report
Jun 1, 2018
Accepted (ET)
Jun 4, 2018 · 5:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jun 1, 2018 | F | 7,168 | — | D | 153,981 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reflected on this Form 4 represent shares surrendered exclusively for the payment of tax obligations as set forth in Mr. Uecker's June 2017 RSU grant agreement previously disclosed and filed on Form 8-K. Mr. Uecker has not sold or in any other way disposed of shares in any manner other than pursuant to the contractual provisions of the RSU agreement.
- F2The market close price of $16.10 per share on June 1, 2018 was used to calculate the number of withheld shares.
- F3Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.